The Australian Government has announced the expansion of free respiratory syncytial virus (RSV) vaccinations under the National Immunisation Program (NIP).
Taking effect from 15 May, the $445.3 million investment will provide Australians aged 75 and older, and Aboriginal and Torres Strait Islander people aged 60 years and older, with the Arexvy RSV vaccine at no cost.
Without listing on the NIP, the RSV vaccination would typically cost $300.
Eligible people can access the vaccine through participating pharmacies, GPs, and community and Aboriginal health services.
More details in tomorrow’s issue of Pharmacy Daily.
